Process for the manufacture of dronedarone
    42.
    发明授权
    Process for the manufacture of dronedarone 失效
    制备决奈达隆的方法

    公开(公告)号:US08536350B2

    公开(公告)日:2013-09-17

    申请号:US13580005

    申请日:2011-01-26

    IPC分类号: A61K31/34 C07D307/00

    CPC分类号: C07D307/82

    摘要: The invention relates to a new process for the preparation of dronedarone and its salts, in particular a synthesis process which allows said compound and its salts to be obtained with good yields, high purity and in an industrially expedient manner; the invention also concerns a new synthesis intermediate.

    摘要翻译: 本发明涉及制备决奈达隆及其盐的新方法,特别是允许以高产率,高纯度和工业上方便的方式获得所述化合物及其盐的合成方法; 本发明还涉及一种新的合成中间体。

    Process for the preparation of 2-amino-1,3-propanediol
    48.
    发明授权
    Process for the preparation of 2-amino-1,3-propanediol 失效
    2-氨基-1,3-丙二醇的制备方法

    公开(公告)号:US5922917A

    公开(公告)日:1999-07-13

    申请号:US704679

    申请日:1996-09-19

    IPC分类号: C07C213/02

    CPC分类号: C07C213/02

    摘要: A process for the preparation of 2-amino-1,3-propanediol comprising the catalytic hydrogenation of 1,3-dihydroxyacetone oxime in the presence of rhodium supported on alumina is described.

    摘要翻译: PCT No.PCT / EP95 / 01245 Sec。 371日期1996年9月9日 102(e)1996年9月9日PCT PCT 1995年4月5日PCT公布。 公开号WO95 / 28379 日期1995年10月26日描述了在负载在氧化铝上的铑存在下,包括1,3-二羟基丙酮肟的催化氢化的2-氨基-1,3-丙二醇的制备方法。

    1,2,3-triazole derivatives useful as modulators of nicotinic acetylcholine receptors
    50.
    发明授权
    1,2,3-triazole derivatives useful as modulators of nicotinic acetylcholine receptors 失效
    1,2,3-三唑衍生物可用作烟碱乙酰胆碱受体的调节剂

    公开(公告)号:US08110588B2

    公开(公告)日:2012-02-07

    申请号:US12672252

    申请日:2008-08-06

    CPC分类号: C07D249/06 C07D413/04

    摘要: This invention relates to novel 1,2,3-triazole derivatives, which are found to be modulators of the nicotinic acetylcholine receptors. Due to their pharmacological profile the compounds of the invention may be useful for the treatment of diseases or disorders as diverse as those related to the cholinergic system of the central nervous system (CNS), the peripheral nervous system (PNS), diseases or disorders related to smooth muscle contraction, endocrine diseases or disorders, diseases or disorders related to neuro-degeneration, diseases or disorders related to inflammation, pain, and withdrawal symptoms caused by the termination of abuse of chemical substances.

    摘要翻译: 本发明涉及新的1,2,3-三唑衍生物,其被发现是烟碱乙酰胆碱受体的调节剂。 由于其药理学特征,本发明的化合物可用于治疗与中枢神经系统(CNS),周围神经系统(PNS),疾病或病症相关的胆碱能系统相关的疾病或障碍 平滑肌肉收缩,内分泌疾病或病症,与神经变性相关的疾病或病症,与由化学物质的滥用终止引起的炎症,疼痛和戒断症状相关的疾病或病症。